MedTrace Logo

Preventive Effects of Ginseng Against Atherosclerosis

NCT02796664 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 58

Last updated 2021-08-24

Study results available
· View outcomes & findings →

Summary

This study is a 12-month, double-blind, randomized, placebo-controlled trial. The purpose of this study is to determine whether ginseng is effective in the prevention of atherosclerosis and subsequent ischemic stroke. High-risk patients with severe atherosclerosis in the major intracranial arteries and extracranial carotid artery were enrolled.

Conditions

Interventions

DIETARY_SUPPLEMENT

Ginseng

Korean Red Ginseng extract tablet (0.5 grams/tablet, 2 tablets twice a day) daily for 12 months.

DIETARY_SUPPLEMENT

Placebo

Placebo (0.5 grams/tablet, 2 tablets twice a day) daily for 12 months.

Sponsors & Collaborators

  • Korea Ginseng Corporation

    collaborator INDUSTRY

  • Dae Chul Suh

    lead OTHER

Principal Investigators

  • Dae Chul Suh · Asan Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-06-23
Primary Completion
2018-07-04
Completion
2018-07-04

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02796664 on ClinicalTrials.gov